PH12017501184A1 - Pharmaceutical composition for treating diabetes - Google Patents

Pharmaceutical composition for treating diabetes

Info

Publication number
PH12017501184A1
PH12017501184A1 PH12017501184A PH12017501184A PH12017501184A1 PH 12017501184 A1 PH12017501184 A1 PH 12017501184A1 PH 12017501184 A PH12017501184 A PH 12017501184A PH 12017501184 A PH12017501184 A PH 12017501184A PH 12017501184 A1 PH12017501184 A1 PH 12017501184A1
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
treating diabetes
dpp
inhibitor
metformin
Prior art date
Application number
PH12017501184A
Other languages
English (en)
Other versions
PH12017501184B1 (en
Inventor
Eon-Pyo Hong
Dong-Wook Kim
Hye-Suk Hong
Jin-Keon Pai
Original Assignee
Handok Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53500898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12017501184(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Handok Inc filed Critical Handok Inc
Publication of PH12017501184B1 publication Critical patent/PH12017501184B1/en
Publication of PH12017501184A1 publication Critical patent/PH12017501184A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
PH12017501184A 2014-12-23 2017-06-22 Pharmaceutical composition for treating diabetes PH12017501184A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140186677A KR101526825B1 (ko) 2014-12-23 2014-12-23 당뇨병 치료용 약제학적 조성물
PCT/KR2015/014096 WO2016105084A2 (ko) 2014-12-23 2015-12-22 당뇨병 치료용 약제학적 조성물

Publications (2)

Publication Number Publication Date
PH12017501184B1 PH12017501184B1 (en) 2017-12-18
PH12017501184A1 true PH12017501184A1 (en) 2017-12-18

Family

ID=53500898

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12017501184A PH12017501184A1 (en) 2014-12-23 2017-06-22 Pharmaceutical composition for treating diabetes

Country Status (7)

Country Link
KR (1) KR101526825B1 (ko)
CN (1) CN107205969B (ko)
MY (1) MY196438A (ko)
PH (1) PH12017501184A1 (ko)
SG (1) SG11201705194XA (ko)
TW (1) TW201628602A (ko)
WO (1) WO2016105084A2 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106421794A (zh) * 2016-09-27 2017-02-22 黑龙江珍宝岛药业股份有限公司 一种用于治疗ⅱ型糖尿病的药物组合物及其制备方法
MX2020002312A (es) * 2017-09-29 2020-09-17 Hanmi Pharm Ind Co Ltd Farmaceutica combinada que comprende dapagliflozina l-prolina y metformina.
KR102500835B1 (ko) * 2017-10-24 2023-02-17 한미약품 주식회사 리나글립틴 및 메트포르민을 포함하는 복합제제 및 그의 제조방법
TR201721824A2 (tr) * 2017-12-26 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
CN113116842A (zh) * 2019-12-31 2021-07-16 广州玻思韬控释药业有限公司 胃滞留片
TW202329921A (zh) * 2021-10-08 2023-08-01 南韓商賽特瑞恩股份有限公司 具有經改善穩定性的用於治療糖尿病的醫藥組合物
CN115715768A (zh) * 2022-11-24 2023-02-28 浙江昂利泰制药有限公司 一种小型西格列汀-二甲双胍缓释片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080630A1 (en) * 2004-09-23 2006-08-03 Handok Pharmaceuticals Co., Ltd. Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
KR101438234B1 (ko) * 2005-06-03 2014-09-04 미쓰비시 타나베 파마 코퍼레이션 의약의 병용 및 그 용도
CN101365432B (zh) * 2005-12-16 2011-06-22 默沙东公司 二肽基肽酶-4抑制剂与二甲双胍的组合的药物组合物
CN101168059A (zh) * 2007-10-12 2008-04-30 重庆医药工业研究院有限责任公司 一种含有双胍、磺酰脲和噻唑烷二酮的稳定的药物组合物及其制备方法
CN101168060B (zh) * 2007-10-12 2012-06-13 重庆医药工业研究院有限责任公司 一种含双胍和磺酰脲的稳定的药物组合物及其制备方法
JP2011510986A (ja) * 2008-02-05 2011-04-07 メルク・シャープ・エンド・ドーム・コーポレイション メトホルミン及びジペプチジルペプチダーゼ−ｉｖ阻害剤の併用医薬組成物
CA2752437C (en) * 2009-02-13 2017-07-11 Boehringer Ingelheim International Gmbh Antidiabetic medications
PL2590634T3 (pl) * 2010-07-09 2016-10-31 Skojarzony system natychmiastowego / opóźnionego uwalniania leków o krótkim okresie półtrwania, w tym remogliflozyny
UY33937A (es) * 2011-03-07 2012-09-28 Boehringer Ingelheim Int Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
US9555001B2 (en) * 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
KR101409330B1 (ko) * 2012-05-11 2014-06-18 안국약품 주식회사 복용순응도가 향상된 서방성 당뇨병 치료용 복합제제 및 이의 제조방법
KR20140013436A (ko) * 2012-07-24 2014-02-05 한미약품 주식회사 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제
CN103285398B (zh) * 2013-06-28 2015-07-22 青岛黄海制药有限责任公司 含有dpp-ⅳ抑制剂和第二种糖尿病药物的复方制剂及其制备方法

Also Published As

Publication number Publication date
SG11201705194XA (en) 2017-07-28
PH12017501184B1 (en) 2017-12-18
MY196438A (en) 2023-04-11
TW201628602A (zh) 2016-08-16
CN107205969A (zh) 2017-09-26
KR101526825B1 (ko) 2015-06-08
WO2016105084A3 (ko) 2016-09-09
WO2016105084A2 (ko) 2016-06-30
CN107205969B (zh) 2020-06-30

Similar Documents

Publication Publication Date Title
PH12017501184A1 (en) Pharmaceutical composition for treating diabetes
CL2016003075A1 (es) Composición para tratar diabetes, que contiene un conjugado de análogo de insulina de acción prolongada y un conjugado de péptido insulinotrópico de acción prolongada
EP3438076C0 (en) USE OF A TYPE OF COMPOUNDS AS ENERGETIC MATERIAL
MX2022003859A (es) Compuestos para usarse en el tratamiento o prevencion de retinitis pigmentosa.
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
EA033325B1 (ru) Ингибиторы бромодомена
ZA201800015B (en) Material for enhancing attributes of a topical or surface treatment composition
HK1256042A1 (zh) 用於治療糖尿病周圍神經病變的hdac抑制劑
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
TN2016000535A1 (en) Ppar compounds for use in the treatment of fibrotic diseases.
MX370412B (es) Compuesto antimicotico.
MX2017000487A (es) Procedimiento de secado.
PH12016501096A1 (en) SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
PH12017501082A1 (en) Calcium carbonate for plant protection
MX2017013739A (es) Vendaje para heridas.
MY181685A (en) Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
EP3362172A4 (en) ADSORPTION MATERIAL FOR THE REMOVAL OF SULFUR HYDROGEN
MX2016013534A (es) Adsorcion y/o reduccion de la cantidad de materiales organicos en un medio acuoso con el uso de carbonato de calcio precipitado coloidal.
MA40027A (fr) Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique
PH12017501897A1 (en) 2-thiopyrimidinones
BR112016015578A2 (pt) Inibidores de 17beta-hidroxiesteroide desidrogenases tipo 1 e tipo 2
MX2017003020A (es) Compuestos de dipeptidil-cetoamida y su uso para el tratamiento y/o la prevencion de la acumulacion de grasa.
MX2016009535A (es) Estuche para el tratamiento de un sustrato.
MX2019010723A (es) Material adsorbente y de envasado.
MY186883A (en) Calcium carbonate for particle boards